NasdaqCM - Nasdaq Real Time Price • USD
Gyre Therapeutics, Inc. (GYRE)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 5:56 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -2.4 | 0.15 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | 113.45M | -- | 113.45M | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | 794k | 113.45M |
Sales Growth (year/est) | -- | -- | 14,188.40% | -- |
Earnings History
CURRENCY IN USD | 9/30/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
---|---|---|---|---|
EPS Est. | -1.5 | -1.05 | -1.05 | -0.75 |
EPS Actual | -2.4 | 0.15 | -1.05 | -1.05 |
Difference | -0.9 | 1.2 | 0 | -0.3 |
Surprise % | -60.00% | 114.30% | 0.00% | -40.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | -0.6 | 0 | -2.4 | -0.45 |
30 Days Ago | -0.6 | 0 | -2.4 | -0.45 |
60 Days Ago | -0.6 | 0 | -2.4 | -0.45 |
90 Days Ago | -0.6 | 0 | -2.4 | -0.45 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | GYRE | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 8.30% |
Next Qtr. | -- | -- | -- | 10.70% |
Current Year | -- | -- | -- | 4.90% |
Next Year | -- | -- | -- | 12.50% |
Next 5 Years (per annum) | -23.33% | -- | -- | 11.23% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
NGNE Neurogene Inc.
37.88
+1.94%
STTK Shattuck Labs, Inc.
7.02
-3.31%
KRBP Kiromic BioPharma, Inc.
2.7500
0.00%
CRVO CervoMed Inc.
19.19
-0.36%
AVBP ArriVent BioPharma, Inc.
18.55
+1.09%
CTNM Contineum Therapeutics, Inc.
16.31
+1.18%
ADAG Adagene Inc.
2.9799
-0.34%
HLVX HilleVax, Inc.
13.54
-1.53%
AEON AEON Biopharma, Inc.
1.6800
+2.44%
NTBL Notable Labs, Ltd.
0.8550
-5.52%